Cargando…

Hormone replacement therapy in rheumatoid arthritis is associated with lower serum levels of soluble IL-6 receptor and higher insulin-like growth factor 1

Hormone replacement therapy (HRT) modulates the imbalance in bone remodeling, thereby decreasing bone loss. Sex hormones are known to influence rheumatic diseases. The aim of this study was to investigate the effects of HRT on the serum levels of hormones and cytokines regulating bone turnover in 88...

Descripción completa

Detalles Bibliográficos
Autores principales:	d'Elia, Helena Forsblad, Mattsson, Lars-Åke, Ohlsson, Claes, Nordborg, Elisabeth, Carlsten, Hans
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC165058/ https://www.ncbi.nlm.nih.gov/pubmed/12823855 http://dx.doi.org/10.1186/ar761

Ejemplares similares

Hormone replacement therapy, calcium and vitamin D(3 )versus calcium and vitamin D(3 )alone decreases markers of cartilage and bone metabolism in rheumatoid arthritis: a randomized controlled trial [ISRCTN46523456]
por: Forsblad d'Elia, Helena, et al.
Publicado: (2004)

Menopause and hormone replacement therapy: effects on the immune system, arthritis and bone
por: Carlsten, H, et al.
Publicado: (2004)

Prevalence and risk factors of vertebral compression fractures in female SLE patients
por: Almehed, Katarina, et al.
Publicado: (2010)

Bone mineral density by digital X-ray radiogrammetry is strongly decreased and associated with joint destruction in long-standing Rheumatoid Arthritis: a cross-sectional study
por: Forsblad-d'Elia, Helena, et al.
Publicado: (2011)

Role of resistin as a marker of inflammation in systemic lupus erythematosus
por: Almehed, Katarina, et al.
Publicado: (2008)

Bone microarchitecture in ankylosing spondylitis and the association with bone mineral density, fractures, and syndesmophytes
por: Klingberg, Eva, et al.
Publicado: (2013)

Cardiac conduction system abnormalities in ankylosing spondylitis: a cross-sectional study
por: Forsblad-d’Elia, Helena, et al.
Publicado: (2013)

Seasonal variations in fatigue in persons with rheumatoid arthritis: a longitudinal study
por: Feldthusen, Caroline, et al.
Publicado: (2016)

Hepatocyte growth factor is a potential biomarker for osteoproliferation and osteoporosis in ankylosing spondylitis
por: Torres, L., et al.
Publicado: (2018)

A longitudinal study of fecal calprotectin and the development of inflammatory bowel disease in ankylosing spondylitis
por: Klingberg, Eva, et al.
Publicado: (2017)

Elevated serum level of hepatocyte growth factor predicts development of new syndesmophytes in men with ankylosing spondylitis
por: Deminger, Anna, et al.
Publicado: (2020)

Osteoporosis in ankylosing spondylitis - prevalence, risk factors and methods of assessment
por: Klingberg, Eva, et al.
Publicado: (2012)

A five-year prospective study of spinal radiographic progression and its predictors in men and women with ankylosing spondylitis
por: Deminger, Anna, et al.
Publicado: (2018)

Weight loss improves disease activity in patients with psoriatic arthritis and obesity: an interventional study
por: Klingberg, Eva, et al.
Publicado: (2019)

Factors associated with changes in volumetric bone mineral density and cortical area in men with ankylosing spondylitis: a 5-year prospective study using HRpQCT.
por: Deminger, A., et al.
Publicado: (2021)

Which measuring site in ankylosing spondylitis is best to detect bone loss and what predicts the decline: results from a 5-year prospective study
por: Deminger, Anna, et al.
Publicado: (2017)

A distinct gut microbiota composition in patients with ankylosing spondylitis is associated with increased levels of fecal calprotectin
por: Klingberg, Eva, et al.
Publicado: (2019)

Decreased levels of T follicular helper (CD4+CXCR5+) cells and CD27+CD38+ and CD27+CD38− B cells in ankylosing spondylitis patients correlate with markers of inflammation
por: Lejon, Kristina, et al.
Publicado: (2022)

Childhood hospitalisation with infections and later development of ankylosing spondylitis: a national case-control study
por: Lindström, Ulf, et al.
Publicado: (2016)

Infliximab Dose Reduction Sustains the Clinical Treatment Effect in Active HLAB27 Positive Ankylosing Spondylitis: A Two-Year Pilot Study
por: Mörck, Boel, et al.
Publicado: (2013)

Patterns of comorbidity and disease characteristics among patients with ankylosing spondylitis—a cross-sectional study
por: Ljung, Lotta, et al.
Publicado: (2017)

Increased proportions of inflammatory T cells and their correlations with cytokines and clinical parameters in patients with ankylosing spondylitis from northern Sweden
por: Lejon, Kristina, et al.
Publicado: (2022)

Perinatal characteristics, older siblings, and risk of ankylosing spondylitis: a case–control study based on national registers
por: Lindström, Ulf, et al.
Publicado: (2016)

Safety of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis as used in clinical practice: results from the ARTIS programme
por: Frisell, Thomas, et al.
Publicado: (2023)

Comparisons between comorbid conditions and health care consumption in rheumatoid arthritis patients with or without biological disease-modifying anti-rheumatic drugs: a register-based study
por: Bengtsson, Karin, et al.
Publicado: (2016)

Role of endogenous and exogenous female sex hormones in arthritis and osteoporosis development in B10.Q-ncf1(*/* )mice with collagen-induced chronic arthritis
por: Jochems, Caroline, et al.
Publicado: (2010)

Increased Insulin Concentrations During Growth Hormone Treatment in Girls With Turner Syndrome Are Ameliorated by Hormone Replacement Therapy
por: Segerer, Sabine Elisabeth, et al.
Publicado: (2020)

Estrogen induces St6gal1 expression and increases IgG sialylation in mice and patients with rheumatoid arthritis: a potential explanation for the increased risk of rheumatoid arthritis in postmenopausal women
por: Engdahl, Cecilia, et al.
Publicado: (2018)

Patient characteristics influence the choice of biological drug in RA, and will make non-TNFi biologics appear more harmful than TNFi biologics
por: Frisell, Thomas, et al.
Publicado: (2018)

Physical function and sex differences in radiographic axial spondyloarthritis: a cross-sectional analysis on Bath Ankylosing Spondylitis Functional Index
por: Hallström, Magnus, et al.
Publicado: (2023)

Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study
por: Bengtsson, Karin, et al.
Publicado: (2017)

Factors related to health-related quality of life in ankylosing spondylitis, overall and stratified by sex
por: Law, Lucy, et al.
Publicado: (2018)

Prevalence and factors related to sleep apnoea in ankylosing spondylitis
por: Wiginder, Adrian, et al.
Publicado: (2021)

Patients with radiographic axial spondylarthritis have an impaired dietary intake—a cross-sectional study with matched controls from northern Sweden
por: Hulander, Erik, et al.
Publicado: (2023)

Estren promotes androgen phenotypes in primary lymphoid organs and submandibular glands
por: Islander, Ulrika, et al.
Publicado: (2005)

Effects of Hormone Replacement Therapy on Insulin Resistance in Postmenopausal Diabetic Women
por: Bitoska, Iskra, et al.
Publicado: (2016)

Cardiac conduction disturbances in patients with ankylosing spondylitis: results from a 5-year follow-up cohort study
por: Bengtsson, Karin, et al.
Publicado: (2019)

Association between serum level of urate and subclinical atherosclerosis: results from the SCAPIS Pilot
por: Drivelegka, Panagiota, et al.
Publicado: (2020)

Osteoporosis in experimental postmenopausal polyarthritis: the relative contributions of estrogen deficiency and inflammation
por: Jochems, Caroline, et al.
Publicado: (2005)

Ncf1 affects osteoclast formation but is not critical for postmenopausal bone loss
por: Stubelius, Alexandra, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_j0lckpn1ifc9mj0g7f79ul1vpg